Designed proteins bind peptides with the highest affinity reported
Using RFdiffusion and ProteinMPNN, researchers designed proteins that bind helical peptides such as glucagon, neuropeptide Y and parathyroid hormone, with what the authors consider the highest reported affinity for a computer-generated biomolecule. They detect low concentrations of peptides in human serum and withstand heat; a parathyroid-hormone biosensor produced a 21-fold increase in bioluminescence. The press release gives no affinity values.
Technology: RFdiffusion and ProteinMPNN
Family RFdiffusion: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Designed binders were tested in the lab for peptide detection (mass spectrometry, including low-concentration peptide detection) and a bioluminescence biosensor produced a 21-fold signal increase with parathyroid hormone; the press release gives no affinity values.
- Still unknown: The abstract does not describe how affinity was measured, does not mention serum testing, and states no limitations; the press release states no limitations.
- AI role: RFdiffusion, extended for flexible targets and partial diffusion, designed binders to helical peptides, de novo or by refining other designs.
Evidence sources: https://www.ipd.uw.edu/2023/12/ai-generates-proteins-with-exceptional-binding-strengths/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06953-1&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 290 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.